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INTRODUCTION
Primary breast sarcomas are rare tumors that originate from 
the mesenchymal tissue of the breast. In a study conducted at 
the Mayo Clinic, the prevalence of primary breast sarcomas 
among breast cancers was found to be 0.0006% [1]. Primary 
leiomyosarcoma of the breast is more rarely observed, and only 
24 cases have been reported in the English medical journals. In 
the present study, we present a case involving primary leio-
myosarcoma of the breast and we discuss optimal treatment 
options.   
CASE REPORT
A 48-year-old female patient was referred to our hospital 
because of pain and a mass in the breast. She noticed a lump 
in her right breast 8 months earlier. In the following months, 
this lump had grown rapidly and led to a tightening of the skin 
of the right breast. 
A physical examination revealed a tender mass that was 10 
cm in size and extended from the upper outer quadrant of the 
right breast to the lower outer quadrant. There was neither   
retraction of the nipple nor palpable axillary or supraclavicular 
lymphadenopathy. The contralateral breast was normal. Mam-
mography and ultrasonography revealed a well-circumscribed 
tumor mass that was 8×6 cm in size and located in the upper 
and lower outer quadrants of the right breast (Figure 1).   
Because of evidence of malignancy in the fine needle aspiration 
biopsy, the patient underwent total mastectomy of the right 
breast, total excision of the pectoralis major muscle due to inva-
sion in the pectoral muscle, and axillary lymph node dissection. 
In the macroscopic pathological examination of the mastec-
tomy specimen, a necrotic tumoral mass that was 10×9×6 cm 
in size was observed and invasion into the overlying breast skin 
and pectoralis major muscle was evident (Figure 2). Micro-
scopically, the tumor was composed of pleomorphic spindle 
cells showing frequent mitoses and necrosis. Tumor cells dem-
onstrated diffuse immunohistochemical staining with smooth 
muscle actin (SMA) (Figures 3-5). No staining was observed 
with desmin, S100, CD117. According to the histopathological 
and immunohistochemical analysis, the tumor was diagnosed 
as leiomyosarcoma.
None of the 31 excised lymph nodes exhibited metastasis, 
and the surgical margins showed no trace of tumor tissue. 
A follow-up thoracoabdominal computed tomography scan 
and bone scintigraphy performed 1 month after the operation 
were normal.     
DISCUSSION
Primary leiomyosarcoma of the breast is rare and is consid-
ered an uncommon breast tumor. Only around 30 cases have 
been reported in English medical journals. Because of the rarity 
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of the tumor more patient data should be presented for the 
development of a proper treatment strategy.
Leiomysarcoma of the breast may originate from the mus-
cular blood vessels or from the smooth muscle of the nipple 
[2,3]. It is quite difficult to diagnose leiomyosarcoma preopera- 
tively [4]. 
Differantial diagnosis includes leiomyoma, spindle cell myo-
epithelioma and spindle cell sarcomatoid carcinomas as seen in 
spindle cell purely epithelial metaplastic carcinomas (spindle 
cell squamous metaplastic carcinoma and adenocarcinoma 
with spindle cell differentiation). In leiomyomas the tumor 
cells bland, without evidence of atypia and mitoses. Tumoral 
necrosis is also not observed. Malign myoepithelioma often 
lacking significant atypia, few mitosis, and at the periphery of 
the lesion, more epitheloid cell population is evident emanating 
Figure 2. Macroscopically, a lobulated elastic tumor that was, 10×9× 
6 cm in size was totally excised.
Figure 3. Histopathology of leiomyosarcoma. Immunostaining for smooth 
muscle actin (SMA) was positive in the malign spindle cells (SMA, ×200).
Figure 1. Preoperative mammogram. (A) A 8×6 cm well-circumscribed 
tumor mass is located in the upper and lower outer quadrants of the 
right breast. (B) The left breast is normal.
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Figure 5. Smooth muscle actin (+) spindle tumour cells (×400).
Figure 4. Spindle shaped tumour cells and mitosis (H&E stain, ×200).126   Zülfikar Karabulut, et al.
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from the myoepithelial cell layer of the entrapped ductules. In 
myoepithelioma tumors cells are SMA (+) and S-100 (+). Meta-
plastic carcinomas of the breast is a general term referring to a 
heterogeneous group of neoplasms. Leiomyosarcoma of the 
breast should be distinguished from spindle cell purely epithe-
lial metaplastic carcinomas (spindle cell squamous metaplastic 
carcinoma and adenocarcinoma with spindle cell differentia-
tion). In spindle cell squamous metaplastic carcinomas, tumor 
cells are epithelial in origin and positive for cytokeratins and 
negative for SMA. In adenocarcinoma with spindle cell meta-
plasia, the tumor is composed of tubules admixed with neo-
plastic spindle cells. These spindle cells immunoreact with   
epithelial markers including Cytokeratin 7 and are negative 
for SMA. In these case the tumor cells demonstrated diffuse 
immunohistochemical staining with SMA. No staining was 
observed with desmin, S100, CD117, pancytokeratin, and     
cytokeratin 7. According to the histopathological appearance 
and immunohistochemical staining, the tumor was diagnosed 
as leiyomyosarcoma.
Establishing an accurate diagnosis is crucial in planning 
treatment. To date, this type of tumor has been observed to 
affect middle-aged women (mean age, 56 years) and manifests 
as a mass in their breast over a long period of time. The average 
tumor size is 4.7 cm [2,4]. Because two of the reported cases 
were in males, the involvement of endocrine factors in this   
tumor appears to be unlikely [2]. This type of tumor tends to 
show local recurrence and distant metastasis has been observed 
in 25% of patients [5,6]. Metastatic spreading usually occurs 
via the hematogenous route. Tumor size is believed to have no 
significant correlation with metastasis [5]. The studies published 
to date show that the tumor presents itself as a long-standing 
and slow-growing mass. The duration of symptoms varies     
between 2 weeks and 5 years, confirming those characteristics 
[5]. Local recurrence and distant metastases can arise even after 
15-20 years [7]. Chen et al. [8] and Nielsen [9] lost their patients 
16 and 20 years, respectively, after the operation due to hepatic 
and multiple metastases. 
The tumor is usually observed as a dense, well-circumscribed, 
fibroadenoma-like mass. It is difficult to reach a diagnosis based 
on fine needle aspiration (FNA) cytology. However, preopera-
tive diagnosis can be achieved using a combination of FNA 
cytology and immunohistochemistry [3,10]. 
Leiomyosarcoma is characterized by spindle-shaped cells 
with pleomorphic, hyperchromatic and elongated nuclei;       
eosinophilic cytoplasm; large nucleoli; and significant mitoses. 
Definitive diagnosis is established through histological exami-
nation, in which positive staining is observed immunohisto-
chemically with desmin, vimentin, and muscle-specific actin, 
whereas negative staining is seen with cytokeratin, myoglobin, 
and S-100 [2]. Because leiomyosarcoma often invades periph-
eral tissues, such as the skin and fascia, curative surgery requires 
a wide resection. Because there has been no reported cases of 
lymph node metastasis in which dissemination occurred via 
the hematogenous route, axillary lymph node dissection is 
unnecessary if leiomyosarcoma diagnosis can be achieved   
before or during the operation [4-6]. In the present case, there 
was no axillary lymph node involvement. Wide resection was 
performed due to the invasion of the pectoralis major muscle 
by the tumor. The benefits of chemotherapy and radiotherapy 
have not yet been confirmed [3,5].
The prognosis of leiomyosarcoma is better than that of other 
breast sarcomas [5]. The prognostic factors are not fully known 
because of the limited number of studies. However, large tumors 
with frequent atypia and mitoses appear to be malignant [2]. 
Based on the published case reports, the characteristics of 
primary leiomyosarcomas of the breast are well-circumscribed, 
slow-growing tumors showing a tendency for skin and muscle 
invasion. In cases where diagnosis can be achieved before or 
during the operation, wide resection should be performed. There 
is no need for axillary lymph node dissection. They require 
long-term follow-up because local recurrence and distant   
metastasis can occur long after the operation. The benefits of 
chemotherapy, radiotherapy, and hormonal therapy are still 
controversial. It has a better prognosis than other breast sarco-
mas. However, there is a need for further studies to determine 
the prognostic factors. 
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